Truist Securities Raises PT to $20, Reiterates Buy Rating on Carlsmed.

viernes, 7 de noviembre de 2025, 11:03 am ET1 min de lectura
CARL--

Truist Securities Raises PT to $20, Reiterates Buy Rating on Carlsmed.

Truist Securities Raises PT to $20, Reiterates Buy Rating on Carlsmed.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios